4
Changes in Ownership
Equillium, Inc. Filed Acc 0001209191-20-025656
Options or other derivatives
- Chief Medical Officer acquired 423,216 shares (grant or award)
- Chief Medical Officer returned 423,216 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Returned to the company · Stock Option (right to buy) | −208,216 | 0 | D | ||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Grant or award · Stock Option (right to buy) | +208,216 | 208,216 | D | ||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Returned to the company · Stock Option (right to buy) | −90,000 | 0 | D | ||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Returned to the company · Stock Option (right to buy) | −125,000 | 0 | D | ||
| Polu Krishna R Chief Medical Officer | 2020-04-22 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D | ||
Loading xslF345X03/doc4.xml…